Additional and booster vaccine doses have been effective in preventing serious COVID-19 in people with HIV and others with immune dysfunction, a large study from the United States reported this week at the 2022 Conference on Retroviruses and Opportunistic Infections.
The study also found that people with immune dysfunction who received an extra dose still had a reduced risk of SARS-CoV-2 infection at least nine months after being fully vaccinated.
Read the full story at Aidsmap.
All Aidsmap reports from CROI 2022.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.